{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:32Z","timestamp":1707524312334},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.7759\/cureus.16848","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T11:19:10Z","timestamp":1627989550000},"source":"Crossref","is-referenced-by-count":0,"title":["Retrohepatic Mass: A Case of Human Herpesvirus-8 Negative Multicentric Castleman\u2019s Disease"],"prefix":"10.7759","author":[{"given":"Hefei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyon J","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harpreet","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinky","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2017.09.004","article-title":"Pathology of Castleman disease","volume":"32","author":"Wu D","year":"2018","unstructured":"Wu D, Lim MS, Jaffe ES. Pathology of Castleman disease. Hematol Oncol Clin North Am. 2018, 32:37-52. 10.1016\/j.hoc.2017.09.004","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2217\/imt.15.95","article-title":"Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease","volume":"8","author":"Fajgenbaum DC","year":"2016","unstructured":"Fajgenbaum DC, Kurzrock R. Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease. Immunotherapy. 2016, 8:17-26. 10.2217\/imt.15.95","journal-title":"Immunotherapy"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2017.09.001","article-title":"Epidemiology of Castleman disease","volume":"32","author":"Simpson D","year":"2018","unstructured":"Simpson D. Epidemiology of Castleman disease. Hematol Oncol Clin North Am. 2018, 32:1-10. 10.1016\/j.hoc.2017.09.001","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2017.11.005","article-title":"Clinical, laboratory and imaging findings in Castleman's disease - the subtype decides","volume":"32","author":"Haap M","year":"2018","unstructured":"Haap M, Wiefels J, Horger M, Hoyer A, M\u00fcssig K. Clinical, laboratory and imaging findings in Castleman's disease - the subtype decides. Blood Rev. 2018, 32:225-234. 10.1016\/j.blre.2017.11.005","journal-title":"Blood Rev"},{"key":"ref5","article-title":"Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy","volume":"8","author":"van Rhee F","year":"2010","unstructured":"van Rhee F, Stone K, Szmania S, Barlogie B, Singh Z. Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol. 2010, 8:486-498.","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2017.09.007","article-title":"Treatment of Kaposi sarcoma herpesvirus-associated multicentric Castleman disease","volume":"32","author":"Lurain K","year":"2018","unstructured":"Lurain K, Yarchoan R, Uldrick TS. Treatment of Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Hematol Oncol Clin North Am. 2018, 32:75-88. 10.1016\/j.hoc.2017.09.007","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.5037","article-title":"Diagnosis and management of Castleman disease","volume":"17","author":"Abramson JS","year":"2019","unstructured":"Abramson JS. Diagnosis and management of Castleman disease. J Natl Compr Canc Netw. 2019, 17:1417-1419. 10.6004\/jnccn.2019.5037","journal-title":"J Natl Compr Canc Netw"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2017.09.002","article-title":"Castleman disease pathogenesis","volume":"32","author":"Fajgenbaum DC","year":"2018","unstructured":"Fajgenbaum DC, Shilling D. Castleman disease pathogenesis. Hematol Oncol Clin North Am. 2018, 32:11-21. 10.1016\/j.hoc.2017.09.002","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2017.09.008","article-title":"Treatment of idiopathic Castleman disease","volume":"32","author":"van Rhee F","year":"2018","unstructured":"van Rhee F, Greenway A, Stone K. Treatment of idiopathic Castleman disease. Hematol Oncol Clin North Am. 2018, 32:89-106. 10.1016\/j.hoc.2017.09.008","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)00006-5","article-title":"Idiopathic multicentric Castleman's disease: a systematic literature review","volume":"3","author":"Liu AY","year":"2016","unstructured":"Liu AY, Nabel CS, Finkelman BS, et al.. Idiopathic multicentric Castleman's disease: a systematic literature review. Lancet Haematol. 2016, 3:163-175. 10.1016\/S2352-3026(16)00006-5","journal-title":"Lancet Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi MO","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011, 7:219-231. 10.1038\/nrendo.2010.217","journal-title":"Nat Rev Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn119","article-title":"Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use","volume":"168","author":"Lee JS","year":"2008","unstructured":"Lee JS, Bracci PM, Holly EA. Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use. Am J Epidemiol. 2008, 168:278-288. 10.1093\/aje\/kwn119","journal-title":"Am J Epidemiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-1123","article-title":"Iron-deficiency anemia in Castleman disease: implication of the interleukin 6\/hepcidin pathway","volume":"126","author":"Arlet JB","year":"2010","unstructured":"Arlet JB, Hermine O, Darnige L, et al.. Iron-deficiency anemia in Castleman disease: implication of the interleukin 6\/hepcidin pathway. Pediatrics. 2010, 126:e1608-e1612. 10.1542\/peds.2010-1123","journal-title":"Pediatrics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum DC","year":"2017","unstructured":"Fajgenbaum DC, Uldrick TS, Bagg A, et al.. International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease. Blood. 2017, 129:1646-1657. 10.1182\/blood-2016-10-746933","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70319-5","article-title":"Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial","volume":"15","author":"Van Rhee F","year":"2014","unstructured":"Van Rhee F, Wong RS, Munshi N, et al.. Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2014, 15:966-974. 10.1016\/S1470-2045(14)70319-5","journal-title":"Lancet Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/62446-retrohepatic-mass-a-case-of-human-herpesvirus-8-negative-multicentric-castlemans-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:06Z","timestamp":1707507186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/62446-retrohepatic-mass-a-case-of-human-herpesvirus-8-negative-multicentric-castlemans-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.16848","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,3]]}}}